415 related articles for article (PubMed ID: 1769066)
41. Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development.
Wen MM
Discov Med; 2011 Jun; 11(61):497-503. PubMed ID: 21712015
[TBL] [Abstract][Full Text] [Related]
42. Buccal mucosa as a route for systemic drug delivery: a review.
Shojaei AH
J Pharm Pharm Sci; 1998; 1(1):15-30. PubMed ID: 10942969
[TBL] [Abstract][Full Text] [Related]
43. Use of vitamin B12 conjugates to deliver protein drugs by the oral route.
Russell-Jones GJ
Crit Rev Ther Drug Carrier Syst; 1998; 15(6):557-86. PubMed ID: 9883390
[TBL] [Abstract][Full Text] [Related]
44. Cyclodextrins: application in different routes of drug administration.
Shimpi S; Chauhan B; Shimpi P
Acta Pharm; 2005 Jun; 55(2):139-56. PubMed ID: 16179128
[TBL] [Abstract][Full Text] [Related]
45. Delivery of anticancer drugs.
Zee-Cheng RK; Cheng CC
Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
[TBL] [Abstract][Full Text] [Related]
46. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
[TBL] [Abstract][Full Text] [Related]
47. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter.
Aungst BJ; Rogers NJ; Shefter E
J Pharmacol Exp Ther; 1988 Jan; 244(1):23-7. PubMed ID: 3275772
[TBL] [Abstract][Full Text] [Related]
48. Noninvasive delivery systems for peptides and proteins in osteoporosis therapy: a retroperspective.
Hoyer H; Perera G; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2010 Jan; 36(1):31-44. PubMed ID: 19640245
[TBL] [Abstract][Full Text] [Related]
49. Enhancing the buccal mucosal delivery of peptide and protein therapeutics.
Caon T; Jin L; Simões CM; Norton RS; Nicolazzo JA
Pharm Res; 2015 Jan; 32(1):1-21. PubMed ID: 25168518
[TBL] [Abstract][Full Text] [Related]
50. Oral colon delivery of insulin with the aid of functional adjuvants.
Maroni A; Zema L; Del Curto MD; Foppoli A; Gazzaniga A
Adv Drug Deliv Rev; 2012 May; 64(6):540-56. PubMed ID: 22086142
[TBL] [Abstract][Full Text] [Related]
51. Oral colon-specific drug delivery of protein and peptide drugs.
Sinha V; Singh A; Kumar RV; Singh S; Kumria R; Bhinge J
Crit Rev Ther Drug Carrier Syst; 2007; 24(1):63-92. PubMed ID: 17430100
[TBL] [Abstract][Full Text] [Related]
52. Investigation of archaeosomes as carriers for oral delivery of peptides.
Li Z; Chen J; Sun W; Xu Y
Biochem Biophys Res Commun; 2010 Apr; 394(2):412-7. PubMed ID: 20226174
[TBL] [Abstract][Full Text] [Related]
53. Review: clinical opportunities provided by the nasal administration of peptides.
Harris AS
J Drug Target; 1993; 1(2):101-16. PubMed ID: 8069548
[TBL] [Abstract][Full Text] [Related]
54. Smart polymers for controlled delivery of proteins and peptides: a review of patents.
Fogueri LR; Singh S
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):40-8. PubMed ID: 19149728
[TBL] [Abstract][Full Text] [Related]
55. Emerging trends in oral delivery of peptide and protein drugs.
Mahato RI; Narang AS; Thoma L; Miller DD
Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):153-214. PubMed ID: 14584523
[TBL] [Abstract][Full Text] [Related]
56. Oral delivery of therapeutic proteins and peptides: a review on recent developments.
Gupta S; Jain A; Chakraborty M; Sahni JK; Ali J; Dang S
Drug Deliv; 2013 Aug; 20(6):237-46. PubMed ID: 23869787
[TBL] [Abstract][Full Text] [Related]
57. [Methodologies for regulation of intestinal absorption of biologically active peptides].
Fujita T; Muranishi S
Nihon Rinsho; 1998 Mar; 56(3):589-94. PubMed ID: 9549341
[TBL] [Abstract][Full Text] [Related]
58. In vivo evaluation of dosage forms: application of gamma scintigraphy to non-enteral routes of administration.
Meseguer G; Gurny R; Buri P
J Drug Target; 1994; 2(4):269-88. PubMed ID: 7858953
[TBL] [Abstract][Full Text] [Related]
59. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
[TBL] [Abstract][Full Text] [Related]
60. Delivery of bioactive peptides and proteins across oral (buccal) mucosa.
Senel S; Kremer M; Nagy K; Squier C
Curr Pharm Biotechnol; 2001 Jun; 2(2):175-86. PubMed ID: 11480421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
